E-Mail
IMAGE: UC Davis and SpectraPass have developed a 20-minute COVID-19 test that pairs a mass spectrometer with a powerful machine-learning platform to detect SARS-CoV-2 in nasal swabs.. view more
Credit: UC Davis Health
A partnership between UC Davis and Maurice J. Gallagher, Jr., chairman and CEO of Allegiant Travel Company, has led to a new rapid COVID-19 test.
A recent study published Nature
Scientific Reports shows the novel method to be 98.3% accurate for positive COVID-19 tests and 96% for negative tests. This test was made from the ground up, said Nam Tran, lead author for the study and a professor of pathology in the UC Davis School of Medicine. Nothing like this test ever existed. We were starting with a clean slate.
February 15, 2021
by Julie Parry
In March of 2020, Shelli Farhadian, MD, PhD, assistant professor of medicine (infectious diseases) and neurology, began to see parallels in her pre-pandemic research on neurologic effects in patients with HIV infection and the possibility of neurologic effects on patients with SARS-CoV-2, or COVID-19.
“There was some literature out there that suggested that coronaviruses could have an effect on the brain. So, knowing that that was a potential possibility, even before we had our first case at Yale New Haven Hospital, I worked with other people to set up a protocol where we could consent patients to collect tissue specimens and information to try to see if this was also going happen with SARS-CoV-2,” explained Farhadian.